OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

MEDIGENE AG NA O.N./  DE000A1X3W00  /

Frankfurt
2024-04-26  4:25:54 PM Chg. +0.0250 Volume Bid9:54:31 PM Ask9:04:15 PM Market Capitalization Dividend Y. P/E Ratio
1.5250EUR +1.67% 3,930
Turnover: 5,933.9500		 -Bid Size: - -Ask Size: - 36.97 mill.EUR 0.00% -
GlobeNewswire 04-26 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 04-25 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 04-17 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 04-08 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...
GlobeNewswire 04-04 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 03-28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-19 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
GlobeNewswire 03-18 Medigene AG to report full year 2023 financial results on March 28, 2024
GlobeNewswire 03-06 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...
GlobeNewswire 03-04 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...
GlobeNewswire 02-29 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...
GlobeNewswire 02-19 Medigene to Present at Upcoming Conferences
GlobeNewswire 02-12 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...
GlobeNewswire 2023-12-19 Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2023-11-21 Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cas...
GlobeNewswire 2023-11-21 Medigene amends 2023 financial guidance
GlobeNewswire 2023-11-04 Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capabil...
GlobeNewswire 2023-10-26 Medigene Reports Financial Results and Corporate Update for Q3 2023
GlobeNewswire 2023-10-23 Medigene presents first pre-clinical data of optimal affinity TCR targeting mKRAS G12V combined with...
GlobeNewswire 2023-10-16 Medigene to present new pre-clinical data for pipeline TCR-T therapies at the ESMO Congress 2023
GlobeNewswire 2023-09-27 Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein
GlobeNewswire 2023-09-18 Medigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Li...
GlobeNewswire 2023-09-11 Medigene AG to present at the Baader Investment Conference 2023
GlobeNewswire 2023-09-05 Medigene AG to present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire 2023-08-30 Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to impro...